Pre-Seed · 2026
think2earn
Open biosensors. Your data pays you.
Open hardware. User-owned biometric data. Onchain payouts.
An open hardware platform for continuous biometric data.
Light-based wearables. Open schematics. User-owned data. Onchain rails to pay contributors.
Hardware
Wearable shipped. Version 2 in production.
Light-based headband & armband. 4 circuit boards manufactured and tested.
Software
Upload. Train. Get paid.
Web app for raw sensor ingestion, model training, and onchain reward claims.
Paired dataset
First open biometric dataset of its kind.
Open-sourced paired light-and-glucose data with reproducible ML pipelines. First beachhead: glucose-trend prediction.
v2 device — controller, enclosure, sensor array
Wear the device. Own your data. Get paid when it’s used.
Three properties that closed competitors can’t copy without killing their business.
OPEN
Schematics and firmware on GitHub. Anyone can build, improve, or audit.
<$500/unit · contract manufacturing
YOURS
Data stays on your device unless you share it. When you share, you earn.
privacy-first · onchain payout
PROVEN
Every payout is cryptographically verifiable. No trust in the platform required.
zero-knowledge ML · onchain receipts
Why now
Optical sensor cost dropped 10× since 2020. Kernel proved brain-grade optics in research wearables — we ship a consumer biosensor under $500.
First beachhead
Glucose-trend prediction from hemoglobin signals — our first paired dataset benchmarks against Abbott Libre 3.
Sell device at 63% margin. Users opt-in for data licensing.
Unit economics — direct-to-consumer
$150
cost at 200 units
$400
retail price
63%
gross margin
0
subscription drag
Quarterly revenue projection — devices + licensing
Device revenue Data licensing
1. Device sales
D2C at $400–600. No subscription.
2. Dataset licensing
Licensing to universities & labs.
3. Premium app
Wellness tracking. Share & earn opt-in for cooperatively training health models.
The flywheel
Device sales → increase user base → raw data → better models → more sales.
The moat
Open hardware. Private dataset. Incumbents can’t copy without killing sensor revenue. Forks start at zero. We compound per unit shipped.
Sales path
Team
Three core contributors: hardware, data analysis, on-chain payouts.
Core
Advisor
Tudor
OpenAI Member of Technical Staff · on leave from Stanford postdoc · ex-CTRL-Labs (Meta).
Collaborator
Grants & recognition
Tokenomics
$T2E · fixed 100M supply
Researchers pay USDC for verified data. 30% of net revenue buys back and burns $T2E.
Supply distribution
Investors & team: 2-yr cliff, 4-yr vest. Emissions are earned through T2E commitments, unlocked when KPIs of verified models and dataset are met.
Where the dollars go
of USDC revenue auto-buys and burns $T2E. With emissions halving every two years, supply goes deflationary by year 3.
Earn
Get paid for what you upload
- — Raw sensor uploads
- — Labeled datasets
- — Reproducible ML models
- — Device purchase bonus
Spend
Pay to access data & devices
- — Dataset licensing for labs
- — Device discount & priority
- — Premium app features
- — Researcher API metering
Govern
Stake $T2E, change protocol settings
- — Vote emission splits
- — Set quality bounties
- — Approve dataset categories
- — Treasury allocation
1 staked $T2E = 1 vote.
The Ask
Ship the platform
- — Manufacture 50 open-hardware units
- — Data ingestion + ML training pipeline
- — Onchain payout rails (Base L2, x402, EIP-3009)
Validate first vertical
- — 100-person glucose-trend trial using continuous glucose monitoring (CGM) and finger pricking data
- — Leave-one-subject-out cross-validation
- — Lock the model. Prove the loop.
Open dataset + working loop
- — First-of-kind paired biometric dataset
- — Validated glucose-trend model in production
- — Clinical evidence pipeline for EU MDR
What you fund
An open biosensor platform, a first-of-kind paired dataset, and the loop proof that unlocks every adjacent vertical.
Regulatory pathway
Launch as wellness & research device today (no FDA/MDR gatekeep). Trial produces clinical evidence for EU MDR. Swiss inc (Zug) = direct pathway.
Open hardware. User-owned data. Onchain payouts.
Open biosensors. Your data pays you. The future of biometric data belongs to the people who generate it.